期刊文献+

MEG3和MALAT-1 lncRNA与垂体生长激素腺瘤发展及侵袭的关系 被引量:1

下载PDF
导出
摘要 目的探索MEG3和MALAT-1长链非编码RNA(lncRNA)的表达与垂体生长激素(GH)腺瘤发展和侵袭的关系。方法应用qRT-PCR检测MEG3和MALAT-1 lncRNA在正常垂体前叶、非侵袭性垂体GH腺瘤、侵袭性垂体GH腺瘤的表达情况,分析其表达差异。结果 MEG3 lncRNA在12例(30.8%)垂体GH腺瘤中表达缺失,在正常垂体前叶无表达缺失。MEG3 lncRNA在侵袭性垂体GH腺瘤(P<0.01)和非侵袭性垂体GH腺瘤(P<0.01)中的表达水平较正常垂体前叶明显降低。MEG3 lncRNA在侵袭性垂体GH腺瘤中的表达水平较非侵袭性垂体GH腺瘤明显降低(P<0.01)。MALAT-1 lncRNA在侵袭性垂体GH腺瘤(P<0.01)和非侵袭性垂体GH腺瘤(P<0.01)中的表达水平较正常垂体前叶明显升高。MALAT-1 lncRNA在侵袭性垂体GH腺瘤中的表达水平较非侵袭性垂体GH腺瘤明显升高(P<0.01)。结论 MEG3 lncRNA的表达缺失与MALAT-1的高表达可能与垂体GH腺瘤的发展和侵袭密切相关。
出处 《广东医学》 CAS 北大核心 2017年第3期410-413,共4页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81271522,81601205) 国家高技术研究发展计划(863计划)项目(编号:2014AA020610)
  • 相关文献

参考文献1

二级参考文献12

  • 1Shao S,Li X.Clinical features and analysis in 1385 Chinese patients with pituitary adenomas[J].J Neurosurg Sci,2013,57 (3):267-275.
  • 2Cordido F,García Arnés JA,Marazuela Aspiroz M,et al.Practical guidelines for diagnosis and treatment of acromegaly[J].Endocrinol Nutr,2013,60(8):457.e1-457.e15.
  • 3Schwyzer L,Starke RM,Jane JA Jr,et al.Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly[J].J Neurosurg,122(4):798-802.
  • 4Mori R,Inoshita N,Takahashi-Fujigasaki J,et al.Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients:classification according to hormone production and cytokeratin distribution[J].ISRN Endocrinol,2013,2013:723432.
  • 5Trouillas J,Sassolas G,Guigard MP,et al.Relationships between pathological diagnosis and clinical parameters in acromegaly[J].Metabolism,1996,45 (8 Suppl 1):53-56.
  • 6Kinoshita Y,Fujii H,Takeshita A,et al.Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic { beta }-cell function is preserved[J].Eur J Endocrinol,2011,164 (4):467-473.
  • 7Jallad RS,Musolino NR,Kodaira S,et al.Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?[J].Clin Endocrinol (Oxf),2007,67 (2):310-315.
  • 8Laws ER,Vance ML,Thapar K.Pituitary surgery for the management of acromegaly[J].Horm Res,2000,53 (Suppl 3):71-75.
  • 9Kreutzer J,Vance ML,Lopes MB,et al.Surgical management of GH-secreting pituitary adenomas:an outcome study using modem remission criteria[J].J Clin Endocrinol Metab,2001,86 (9):4072-4077.
  • 10Kim EH,Oh MC,Lee EJ,et al.Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly[J].Neurosurgery,2012,70(5):1106-1113.

共引文献10

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部